Liver Tumour Tissue Microarray for Cancer Research
Tissue microarrays (TMAs) are highly efficient research platforms that combine multiple tissue samples into a single paraffin block for simultaneous analysis. This format allows for high-throughput screening, consistent staining, and reduced variability across large patient cohorts. A liver tumour tissue microarray provides a valuable resource for studying hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver cancers. Researchers can investigate tumour heterogeneity, fibrosis patterns, vascular invasion, and biomarker expression critical to liver cancer progression and treatment.
Liver tumour TMAs are most frequently used in immunohistochemistry (IHC) and hematoxylin and eosin (H&E) staining. IHC helps detect key markers such as AFP, HepPar-1, Glypican-3, and CK7/CK19, which aid in tumour classification and prognostication. H&E staining reveals histological features like trabecular patterns, cellular atypia, and necrosis, offering foundational insight into tumour grading and staging. Together, these staining techniques allow researchers to perform robust comparative analysis across a diverse liver cancer cohort, accelerating discoveries in hepatology and oncology.
Role of Tissue Microarrays in TME Research
Tissue microarrays have transformed how researchers explore the tumour microenvironment (TME). They enable high-throughput analysis of multiple tissue samples simultaneously, making them essential for identifying biomarkers, conducting immune profiling, and performing spatial analysis. TMAs allow researchers to map immune cell infiltration, tumour heterogeneity, and stromal interactions across a broad cohort. Because human-derived TMAs preserve spatial organization, they provide a more accurate representation of the TME compared to animal models. This accelerates the validation of predictive biomarkers and improves the understanding of therapy response, ultimately pushing forward the development of personalised cancer treatment strategies.
Why Choose MYmAb Biologics' Tissue Microarray Over Others
What sets MYmAb Biologics apart is more than just technical quality. It’s the depth and relevance of our source material:
- SEA Sourced Sample: Our tissue microarrays are sourced from Southeast Asian samples, offering distinct population-specific insights that are often missing from Western-focused arrays.
- Fully Consented: Every sample comes from donors who have given informed consent, supporting ethical research standards.
- Comprehensive Data: Each array is curated for metadata richness, covering tumour type, grade, stage, and patient demographics when available.
- Global Delivery: We deliver worldwide with reliable logistics and clear documentation, making our TMAs accessible to researchers everywhere.
我们还提供以下专业服务